COST-EFFECTIVENESS OF TREATING ACUTE CORONARY SYNDROME PATIENTS WITH RIVAROXBAN IN AUSTRALIA

被引:0
|
作者
Gao, L. [1 ]
Li, S. C. [1 ]
机构
[1] Univ Newcastle, Callaghan, NSW 2308, Australia
关键词
D O I
10.1016/j.jval.2014.08.255
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCV30
引用
收藏
页码:A760 / A760
页数:1
相关论文
共 50 条
  • [41] Cost-Effectiveness of Ticagrelor Compared with Clopidogrel in Patients with Acute Coronary Syndrome from Vietnamese Healthcare Payers’ Perspective
    Thuy Thi Thu Nguyen
    Dung Van Do
    Carl Mellstrom
    Tuan Quang Nguyen
    Hung Manh Pham
    Sy Van Hoang
    Thinh Cong Luu
    Tri Le Phuong
    Advances in Therapy, 2021, 38 : 4026 - 4039
  • [42] Cost-Effectiveness of Ticagrelor Compared with Clopidogrel in Patients with Acute Coronary Syndrome from Vietnamese Healthcare Payers' Perspective
    Thuy Thi Thu Nguyen
    Dung Van Do
    Mellstrom, Carl
    Tuan Quang Nguyen
    Hung Manh Pham
    Sy Van Hoang
    Thinh Cong Luu
    Tri Le Phuong
    ADVANCES IN THERAPY, 2021, 38 (07) : 4026 - 4039
  • [43] COST-EFFECTIVENESS OF FONDAPARINUX AND ENOXAPARIN IN PATIENTS WITH NON ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME IN BRAZIL
    Pepe, C.
    Machado, M.
    Olimpio, A.
    Canella, M.
    Ramos, R.
    VALUE IN HEALTH, 2011, 14 (03) : A40 - A41
  • [44] COST-EFFECTIVENESS OF TICAGRELOR COMPARED WITH CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME FROM A VIETNAMESE HEALTHCARE PAYERS' PERSPECTIVE
    Do, V. D.
    Nguyen, T. T.
    Mellstrom, C.
    Nguyen, Q. T.
    Pham, M. H.
    Hoang, V. S.
    Phuong, L. T.
    Luu, T. C.
    VALUE IN HEALTH, 2018, 21 : S2 - S2
  • [45] A Cost-Effectiveness Analysis of Clopidogrel for Patients with Non-ST-Segment Elevation Acute Coronary Syndrome in China
    Cui, Ming
    Tu, Chen Chen
    Chen, Er Zhen
    Wang, Xiao Li
    Tan, Seng Chuen
    Chen, Can
    ADVANCES IN THERAPY, 2016, 33 (09) : 1600 - 1611
  • [46] COST-EFFECTIVENESS OF UNIVERSAL OR GENOTYPE DRIVEN USE OF AVAILABLE DUAL ANTIPLATELET STRATEGIES IN PATIENTS WITH ACUTE CORONARY SYNDROME
    Lee, Soyon
    Dhamija, Asha
    Parsons, Katelyn
    King, Matthew
    Kaur, Rajbir
    Roberts, Matthew
    Coleman, Craig
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E483 - E483
  • [47] Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany
    Ulrike Theidel
    Christian Asseburg
    Evangelos Giannitsis
    Hugo Katus
    Clinical Research in Cardiology, 2013, 102 : 447 - 458
  • [48] A Cost-Effectiveness Analysis of Clopidogrel for Patients with Non-ST-Segment Elevation Acute Coronary Syndrome in China
    Ming Cui
    Chen Chen Tu
    Er Zhen Chen
    Xiao Li Wang
    Seng Chuen Tan
    Can Chen
    Advances in Therapy, 2016, 33 : 1600 - 1611
  • [49] Cost effectiveness of influenza vaccination in patients with acute coronary syndrome in Korea
    Suh, Jinuk
    Kim, Boyeon
    Yang, Yunseok
    Suh, Dong-Churl
    Kim, Eunyoung
    VACCINE, 2017, 35 (21) : 2811 - 2817
  • [50] Cost-effectiveness analysis of genotype-guided antiplatelet therapy in patients with acute coronary syndrome and planned percutaneous coronary intervention.
    Lin, Fang-Ju
    Patel, Vardhaman
    Ojo, Olaitan
    Rao, Sapna
    Yu, Shengsheng
    Zhan, Lin
    Touchette, Daniel R.
    PHARMACOTHERAPY, 2012, 32 (10): : E300 - E300